|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | |
| C07D 487/04 | |||
| A61K 31/395 | |||
| A61P 17/00 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Patento numeris | 2343298 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11152674.5 |
| Europos patento paraiškos padavimo data | 2006-12-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-07-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 749905 P | 2005-12-13 | US | |
| 810231 P | 2006-06-02 | US | |
| 850625 P | 2006-10-10 | US | |
| 856872 P | 2006-11-03 | US | |
| 859404 P | 2006-11-16 | US |
| (72) |
Rodgers, James D., US
Shepard, Stacey, US
Maduskuie, Thomas P., US
Wang, Haisheng, US
Falahatpisheh, Nikoo, US
Rafalski, Maria, US
Arvanitis, Argyrios G., US
Storace, Louis, US
Jalluri, Ravi Kumar, US
Fridman, Jordan S., US
Vaddi, Krishna, US
|
| (73) |
Incyte Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (54) | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |